Form 8-K - Current report:
SEC Accession No. 0001193125-12-441915
Filing Date
2012-10-31
Accepted
2012-10-30 19:31:39
Documents
3
Period of Report
2012-10-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d431185d8k.htm 8-K 14983
2 PRESS RELEASE d431185dex991.htm EX-99.1 11754
3 GRAPHIC g431185g49j14.jpg GRAPHIC 6051
  Complete submission text file 0001193125-12-441915.txt   36357
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27436 | Film No.: 121169448
SIC: 2836 Biological Products, (No Diagnostic Substances)